124 related articles for article (PubMed ID: 10673089)
1. Synthesis and biological activities of hapalosin derivatives with modification at the C12 position.
Kashihara N; To-e S; Nakamura K; Umezawa K; Yamamura S; Nishiyama S
Bioorg Med Chem Lett; 2000 Jan; 10(2):101-3. PubMed ID: 10673089
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis and conformational studies of hapalosin, N-desmethylhapalosin and 8-deoxyhapalosin.
Wagner B; Gonzalez GI; Tran Hun Dau ME; Zhu J
Bioorg Med Chem; 1999 May; 7(5):737-47. PubMed ID: 10400327
[TBL] [Abstract][Full Text] [Related]
3. A practical total synthesis of hapalosin, a 12-membered cyclic depsipeptide with multidrug resistance-reversing activity, by employing improved segment coupling and macrolactonization.
Palomo C; Oiarbide M; García JM; González A; Pazos R; Odriozola JM; Bañuelos P; Tello M; Linden A
J Org Chem; 2004 Jun; 69(12):4126-34. PubMed ID: 15176838
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of the multidrug resistance-reversing activity of D-glucose mimetics of hapalosin.
Dinh TQ; Smith CD; Du X; Armstrong RW
J Med Chem; 1998 Mar; 41(6):981-7. PubMed ID: 9526572
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of hapalosin and analogs as MDR-reversing agents.
O'Connell CE; Salvato KA; Meng Z; Littlefield BA; Schwartz CE
Bioorg Med Chem Lett; 1999 Jun; 9(11):1541-6. PubMed ID: 10386932
[TBL] [Abstract][Full Text] [Related]
6. Diversity-oriented asymmetric synthesis of hapalosin: construction of three small C9/C4/C3-modified hapalosin analogue libraries.
Dai CF; Cheng F; Xu HC; Ruan YP; Huang PQ
J Comb Chem; 2007; 9(3):386-94. PubMed ID: 17358084
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
[TBL] [Abstract][Full Text] [Related]
9. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytostatic activities of didemnin derivatives.
Schmidt U; Griesser H; Haas G; Kroner M; Riedl B; Schumacher A; Sutoris F; Haupt A; Emling F
J Pept Res; 1999 Aug; 54(2):146-61. PubMed ID: 10461749
[TBL] [Abstract][Full Text] [Related]
11. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel bioactive peptides and peptidomimetics.
Freidinger RM
J Med Chem; 2003 Dec; 46(26):5553-66. PubMed ID: 14667208
[No Abstract] [Full Text] [Related]
13. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
14. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Shih C; Teicher BA
Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
[TBL] [Abstract][Full Text] [Related]
15. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
Al-Awar RS; Corbett TH; Ray JE; Polin L; Kennedy JH; Wagner MM; Williams DC
Mol Cancer Ther; 2004 Sep; 3(9):1061-7. PubMed ID: 15367700
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, Biological Activity, and Structural Analysis of Lactam-Constrained PTPRJ Agonist Peptides.
Sala M; Spensiero A; Scala MC; Pepe G; Bilotta A; Paduano F; D'Agostino S; Lanzillotta D; Bertamino A; Novellino E; Trapasso F; Gomez-Monterrey IM; Campiglia P
ChemMedChem; 2018 Aug; 13(16):1673-1680. PubMed ID: 29888867
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine region.
Shih C; Gossett LS; Gruber JM; Grossman CS; Andis SL; Schultz RM; Worzalla JF; Corbett TH; Metz JT
Bioorg Med Chem Lett; 1999 Jan; 9(1):69-74. PubMed ID: 9990459
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of gamma-aryl substituted alpha-alkylidene-gamma-lactones and alpha-alkylidene-gamma-lactams.
Albrecht A; Koszuk JF; Modranka J; Rózalski M; Krajewska U; Janecka A; Studzian K; Janecki T
Bioorg Med Chem; 2008 May; 16(9):4872-82. PubMed ID: 18396404
[TBL] [Abstract][Full Text] [Related]
20. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
